Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001241791 | SCV001414834 | uncertain significance | Aicardi-Goutieres syndrome 2 | 2022-10-10 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with glutamine, which is neutral and polar, at codon 233 of the RNASEH2B protein (p.Lys233Gln). This variant is present in population databases (rs774950202, gnomAD 0.006%). This missense change has been observed in individual(s) with clinical features of systemic lupus erythematosus (PMID: 25500883). ClinVar contains an entry for this variant (Variation ID: 966986). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects RNASEH2B function (PMID: 25500883). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |